At CARMA Nanovectors, we develop high-performance nanoscale delivery platforms engineered to enhance the efficacy, stability, and targeted delivery of therapeutic and bioactive ingredients.
Our portfolio includes biomimetic lipid-based nanovesicles and advanced nanopolymer systems designed for therapeutic and nutraceutical applications. Through our licensing model, partners gain access to ready-to-develop formulations, optimized process parameters, and comprehensive technical data, supporting seamless scale-up and manufacturing with qualified CDMOs and GMP-certified production partners.
Explore our nanocarrier prototype categories and their application areas.
Bioinspired lipid nanocarrier prototypes copied by the structure and functionality of natural extracellular vesicles (EVs) and exosomes are our advanced system. The proprietary platform combines the safety, scalability, and manufacturing advantages of synthetic lipid nanoparticles with the biological activity of selected membrane proteins, creating hybrid nanovesicles that enhance targeted delivery while reducing the protein corona effect, a major limitation of conventional nanocarriers. The result is a versatile and scalable delivery technology designed for research, preclinical development, and commercial applications.
Our nano-vectors uses ionizable lipids to bind amino acids and peptides, protecting them during gastrointestinal transit and improving bioavailability, enabling lower doses and enhanced use.
Our nano-vectors enables the direct delivery of transmembrane CAR proteins to circulating T cells, providing a non-genetic approach to transient immune cell engineering with potential applications against solid tumors.
Our nano-vectors combines ionizable lipids with platelet-derived membrane components to improve circulation, reduce immune recognition, and enhance intracellular delivery of nucleic acid therapeutics for gene therapy or RNA interference.
Our delivery platform can be assembled as biohybrid with human Stem Cells Extracellular Vesicles (EVs), combining the biomimetic properties of natural EV membranes with the scalability and formulation flexibility of synthetic lipid nanoparticles. This hybrid design enhances biological functionality, reduces protein corona formation, and enables efficient, targeted delivery of therapeutic payloads.
The Platform enables the design and fabrication of biopolymer-based nanocarrier prototypes for targeted delivery across research, preclinical development, and commercial applications. Built on biodegradable polymers such as PLA (polylactic acid) and PLGA (poly(lactic-co-glycolic acid)), the platform provides a versatile, scalable, and customizable technology for the encapsulation and controlled release of a wide range of functional compounds.
Biopolymer nanovectors engineered with PLA and PLGA matrices for the encapsulation and controlled delivery of metal oxide nanoparticles, supporting applications in diagnostics, imaging, and advanced biomedical research.
Biodegradable nanocarriers designed to protect and deliver bioactive peptides, including growth factors and therapeutic peptides, enhancing stability, controlled release, and biological performance.
Polymeric nanoprobes incorporating fluorescent dyes for imaging, tracking, and analytical applications. These nanocarriers enable the study of biological processes, cellular interactions, and material behavior, providing powerful tools for research, diagnostics, and biosensing.
From early-stage research to preclinical development, CARMA offers tailored solutions to support your nanomedicine journey.
Tailored nanocarrier design to meet your specific payload and application requirements.
Optimization of formulations for efficiency, stability, and scalability.
Comprehensive physicochemical and biological characterization.
We work closely with academic and industrial partners to accelerate innovation.